I found these links on the web. They led to some good info....

• Drug approval process: NOW. Science & Health. What's in the Medicine Cabinet? The FDA and Drug Approval Overview | PBS
• Food and Drug Administration view on medical marijuana: Marijuana Concerns
• National Academy of Sciences Institute of Medicine report on marijuana and cannabinoids: Marijuana as Medicine - Assessing the Science Base - Institute of Medicine Report
• marijuana use and heart attack risk: Harvard Medicine
• THC toxicity: Cannabidiol: The Wonder Drug of the 21st Century?
• Cannabidiol information: Acute Effects of Marijuana (Delta 9 THC) - Lethality
• Sativex information: Sativex GW Pharmaceuticals Cannabis Medicine
• Addictiveness of common drugs (such as nicotine, marijuana, heroin): Relative Addictiveness of Drugs (NYT 8/2/94)
• Nicotine addiction: Nicotine Addiction
• Drug Policy Alliance: Marijuana
• Drug Enforcement Agency marijuana information: DEA Briefs & Background, Drugs and Drug Abuse, Drug Descriptions, Marijuana
• San Francisco Cannabis Clubs: San Francisco Cannabis Clubs
• The National Organization for the Reform of marijuana Laws: Marijuana Law Reform - NORML
• Rajesh M, Mukhopadhyay P, Bátkai S, Haskó G, Liaudet L, Drel VR, Obrosova IG, Pacher P. Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption. Am J Physiol Heart Circ Physiol. 2007 Jul;293(1):H610-9. Epub 2007 Mar 23. PMID 17384130
• Melamede R. Cannabis and tobacco smoke are not equally carcinogenic. Harm Reduct J 2005;2:21. Cannabis and tobacco smoke are not equally carcinogenic PMID 16232311
• Earleywine M, Barnwell SS. Decreased respiratory symptoms in cannabis users who vaporize. Harm Reduct J. 2007 Apr 16;4:11. Decreased respiratory symptoms in cannabis users who vaporize PMID 17437626
• Hampson AJ, Grimaldi M, Axelrod J, Wink D. Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants. Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8268-73. Cannabidiol and (&#x02212Δ9-tetrahydrocannabinol are neuroprotective antioxidants PMID 9653176
• Zuardi AW, Crippa JA, Hallak JE, Moreira FA, Guimarães FS. Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug. Braz J Med Biol Res. 2006 Apr;39(4):421-9. Epub 2006 Apr 3. Review. Brazilian Journal of Medical and Biological Research - Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug PMID 16612464
• Hamelink C, Hampson A, Wink DA, Eiden LE, Eskay RL. Comparison of cannabidiol, antioxidants, and diuretics in reversing binge ethanol-induced neurotoxicity. J Pharmacol Exp Ther. 2005 Aug;314(2):780-8. Epub 2005 May 5. Comparison of Cannabidiol, Antioxidants, and Diuretics in Reversing Binge Ethanol-Induced Neurotoxicity -- Hamelink et al. 314 (2): 780 -- Journal of Pharmacology And Experimental Therapeutics PMID 15878999
• McCarberg BH. Cannabinoids:their role in pain and palliation. J Pain Palliat Care Pharmacother. 2007;21(3):19-28. PMID 18032352
• Ashton CH, Moore PB, Gallagher P, Young AH. Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential. J Psychopharmacol. 2005 May;19(3):293-300. PMID 15888515
• Preet A, Ganju RK, Groopman JE. Delta(9)-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo. Oncogene. 2007 Jul 9. PMID 17621270
• Robson P. Human studies of cannabinoids and medicinal cannabis. Handb Exp Pharmacol. 2005;(16:719-56. PMID 16596794
• Beaulieu P. Toxic effects of cannabis and cannabinoids: Animal data. Pain Res Manag. 2005 Autumn;10 Suppl A:23A-6A. PMID 16237478
• Seamon MJ, Fass JA, Maniscalco-Feichtl M, Abu-Shraie NA. Medical marijuana and the developing role of the pharmacist. Am J Health Syst Pharm. 2007 May 15;64(10):1037-44. Review. PMID 17494903
• Coulston CM, Perdices M, Tennant CC. The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues. Aust N Z J Psychiatry. 2007 Nov;41(11):869-84. PMID 17924240
• Barnes MP. Sativex: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain. Expert Opin Pharmacother. 2006 Apr;7(5):607-15. Review. PMID 16553576
• Iskedjian M, Bereza B, Gordon A, Piwko C, Einarson TR. Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain. Curr Med Res Opin. 2007 Jan;23(1):17-24. PMID 17257464
• McGilveray IJ. Pharmacokinetics of cannabinoids. Pain Res Manage 2005;10(Suppl A):15A-22A. PMID 16237477

__________________
Enjoying the ongoing exierence of acquiring knowledge of this shit....OH YEAH, REP IS MUCH APPRECIATED!!!